|
|
Article: Timing of Postmenopausal Hormone Therapy a Critical Factor in Heart Disease Risk Says Study in Journal of Women's Health.
- Article from:
- Business Wire
- Article date:
- January 19, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW ROCHELLE, N.Y. -- The timing of estrogen replacement therapy in relation to a woman's age and time since onset of menopause may be a critical factor in whether hormone therapy protects against coronary heart disease, according to a report in the January/February 2006 issue (Vol. 15, No. 1) of Journal of Women's Health, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The paper is available free online at www.liebertpub.com/jwh.
In the paper entitled, "Hormone Therapy and Coronary Heart Disease: The Role of Time Since Menopause and Age at Hormone Initiation," co-authors Francine Grodstein, Sc.D., JoAnn Manson, M.D., Dr.Ph., and ...